About Our Company

PathCision Medicine is pioneering the development of precision medicines to address oncology and other diseases with critical unmet needs. Its innovation is powered by PathCision's proprietary machine learning-enabled multi-omics platform, which leverages deep insights from tissue pathology to unveil novel therapeutic pathways, setting a new standard in targeted treatment strategies.